Clinical trial
Topiramate for Alcohol and Cocaine Dependence
NCT00167245 · Kyle Kampman, Other · Completed
Key facts
| NCT number | NCT00167245 |
|---|---|
| Title | Topiramate for Alcohol and Cocaine Dependence |
| Official title | A Phase II, Randomized, Double-blind, Placebo-Controlled, Pilot Trial of Topiramate for Alcohol and Comorbid Cocaine Dependence |
| Acronym | TOP2 |
| Lead sponsor | Kyle Kampman, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism, Cocaine Dependence |
| Intervention type | Drug |
| Interventions | Topiramate, placebo |
| Enrollment | 170 |
| Start date | Sep 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Sep 14, 2005 |
| Last update posted | Jul 7, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: